Domedrag D Capsule contains Domperidone 30mg + Dexrabeprazole 30mg, an advanced dual-action formulation developed for effective control of severe acid reflux, persistent GERD symptoms, and upper gastrointestinal motility disorders. This combination targets both excess acid secretion and delayed gastric emptying for comprehensive symptom relief.
Dexrabeprazole, a next-generation proton pump inhibitor, provides faster and more sustained acid suppression, while Domperidone enhances gastric motility and prevents reflux-related nausea and vomiting. Together, they improve digestive comfort, reduce heartburn, and support faster symptom resolution in chronic acid-related conditions.
For distributors, hospitals, and pharmacy chains, Domedrag D Capsule is a high-rotation gastroenterology product, commonly prescribed in cases of moderate to severe GERD, refractory acidity, and dyspepsia. Long-term treatment requirements ensure steady demand and repeat procurement across healthcare settings.
Adding Domedrag D Capsule to your portfolio strengthens your gastrointestinal and acid-control therapy segment, opening opportunities in hospital procurement, retail pharmacy supply, export markets, and third-party manufacturing. Its high-strength composition and strong clinical acceptance make it a strategically valuable product for pharmaceutical distributors.